Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease
Authors
Keywords
-
Journal
JAMA Surgery
Volume -, Issue -, Pages e210891
Publisher
American Medical Association (AMA)
Online
2021-04-22
DOI
10.1001/jamasurg.2021.0891
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
- (2020) J. M. Simons et al. BREAST CANCER RESEARCH AND TREATMENT
- Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla
- (2019) Zhao Bi et al. Breast Cancer
- Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype
- (2019) Rosa Di Micco et al. EJSO
- Subtype-guided 18F-FDG PET/CT in tailoring axillary surgery among node-positive breast cancer patients treated with neoadjuvant chemotherapy: a feasibility study
- (2019) S. Wu et al. BREAST
- Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
- (2019) Hee Jun Choi et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer
- (2019) Stephanie M. Wong et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis
- (2019) Stephanie M. Wong et al. ANNALS OF SURGICAL ONCOLOGY
- Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype
- (2019) Antonia Glaeser et al. ANNALS OF SURGICAL ONCOLOGY
- Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
- (2019) Samia Al-Hattali et al. CANCER IMAGING
- Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment
- (2018) Linda T. Qu et al. AMERICAN JOURNAL OF SURGERY
- A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer
- (2018) Olga Kantor et al. ANNALS OF SURGICAL ONCOLOGY
- Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm
- (2018) Richard Ha et al. ANNALS OF SURGICAL ONCOLOGY
- Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
- (2018) Toan T. Nguyen et al. ANNALS OF SURGICAL ONCOLOGY
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies
- (2018) Matthew D. F. McInnes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma
- (2018) Uanderson Resende et al. ONCOLOGY
- Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer
- (2018) Lobna Ouldamer et al. SURGICAL ONCOLOGY-OXFORD
- The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)
- (2018) Oluwadamilola M. Fayanju et al. ANNALS OF SURGERY
- Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer
- (2018) Janine M. Simons et al. ANNALS OF SURGERY
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery
- (2017) Audree B. Tadros et al. JAMA Surgery
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer
- (2016) Katsutoshi Enokido et al. Clinical Breast Cancer
- Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands
- (2016) G. Vugts et al. EJSO
- Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
- (2016) Abigail S. Caudle et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy
- (2016) Jennifer Steiman et al. JOURNAL OF SURGICAL RESEARCH
- Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy
- (2016) Sarah S. Mougalian et al. JAMA Oncology
- Unknown
- (2016) CANCER
- Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients
- (2015) Mila Donker et al. ANNALS OF SURGERY
- The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis
- (2015) T.J.A. van Nijnatten et al. EJSO
- Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
- (2015) Jean-Francois Boileau et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer
- (2015) Jee Ye Kim et al. MEDICINE
- A Model to Predict Pathologic Complete Response of Axillary Lymph Nodes to Neoadjuvant Chemo(Immuno)Therapy in Patients With Clinically Node-Positive Breast Cancer
- (2014) Robert-Jan Schipper et al. Clinical Breast Cancer
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla
- (2013) Bas B. Koolen et al. ANNALS OF SURGICAL ONCOLOGY
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Cytologically Proven Node-positive Breast Cancer at Diagnosis
- (2013) Seho Park et al. ANNALS OF SURGICAL ONCOLOGY
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
- (2013) Judy C. Boughey JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
- (2013) Thorsten Kuehn et al. LANCET ONCOLOGY
- Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
- (2012) Nehmat Houssami et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now